Litcius/Paper detail

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, Venkata S. Bollimpelli, Arun K. Boddapati, Ayalnesh Shiferaw, Sheikh Abdul Rahman, Anusmita Sahoo, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd, Shelly Wang, Stephanie Fischinger, Caroline Atyeo, Sally Shin, Sanjeev Gumber, Shannon G. M. Kirejczyk, Joyce Cohen, Sherrie Jean, Jennifer Wood, Fawn Connor‐Stroud, Rachelle L. Stammen, Amit A. Upadhyay, Kathryn L. Pellegrini, David C. Montefiori, Pei‐Yong Shi, Vineet D. Menachery, Galit Alter, Thomas H. Vanderford, Steven E. Bosinger, Mehul S. Suthar, Rama Rao Amara

2021Immunity91 citationsDOIOpen Access PDF

Topics & Concepts

VacciniaVirologyVaccinationAntibodyImmune systemBiologyModified vaccinia AnkaraImmunologyNeutralizing antibodyCoronavirusPandemicImmunityCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineInfectious disease (medical specialty)DiseasePathologyRecombinant DNAGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs | Litcius